Calling All COVID-19 Researchers: Rescale Team Wants to Help
Rescale, Google Cloud Platform, and Microsoft Azure report they will fund millions in computing for those working on COVID-19 research.
Engineering Computing News
Engineering Computing Resources
April 1, 2020
Historically, supercomputers have traditionally been limited to people who are physically close by. But as COVID-19 forces more people to work remotely, cloud supercomputers create power that can be accessed anywhere, empowering the best engineers, scientists and researchers to collaborate in real time from anywhere in the world.
To help deliver this capability to the community, Rescale, Google Cloud Platform, and Microsoft Azure report they will fund millions in computing for those working on COVID-19 research. They say the goal is to provide scientists and researchers everything they need to run life sciences simulations, from simulation workflow automation to the underlying compute and storage resources, to accelerate a fast path to combating the disease.
Cloud supercomputers, or high-performance computing (HPC), can be used to model how the virus spreads in the population, develop test kits and to create vaccines. Scientists and researchers are already making strides harnessing HPC to tackle this pandemic. The companies say they can make it easier to get use cases and workflows enabled on the cloud, and they report they can make it easier to eliminate technical barriers and cost limitations to maximize scale and performance.
With this effort, for examples, Rescale supports the following computational methods to help researchers to automate workflows and use cloud computing resources:
- Model outbreak scenarios with large-scale COVID-19 simulations, to forecast coronavirus spread and inform public health policies
- Monitoring and risk analytics for the 2019 novel coronavirus (COVID-19) epidemic
- Accelerate development of COVID-19 test kits to help computationally design tests mapped to the genetic data model of COVID-19
- Identify genomic variants, which predispose individuals to resistance or progression of COVID-19 to help combat the disease
- Accelerate development of a COVID-19 vaccine by inhibiting the virus’ replication
Sources: Press materials received from the company and additional information gleaned from the company’s website.
More Rescale Coverage
About the Author
DE’s editors contribute news and new product announcements to Digital Engineering. Press releases can be sent to them via [email protected].Follow DE